Raymond Prudo-Chlebosz - Director at Akari Therapeutics Plc

Issuer-level insider activity

Role: Director
Issuer ticker: AKTX on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

Past-year transaction volume for Raymond Prudo-Chlebosz in Akari Therapeutics Plc

Buys

Open market

Shares: +1,005,319
Avg price: $0.4041
Total value: +$406,249

Sells

Open market

Shares
Avg price
Total value

Net

Past year

Shares: +1,005,319
Share %: 100%
Total value: +$406,249

Reported holdings for Raymond Prudo-Chlebosz in Akari Therapeutics Plc

Form 4 holding Director

Akari Therapeutics Plc

Security class: American Depositary Shares representing Ordinary Shares
Shares / value: 2,484,990
Estimated value: $2,783,189
Report date: 20 Mar 2025
Price: $1.12
Ownership: Direct

Form 4 holding Director

Akari Therapeutics Plc

Security class: Series A Warrants (Right to Buy)
Shares / value: 446,428
Estimated value: $499,999
Report date: 06 Mar 2025
Price: $1.12
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Series B Warrants (Right to Buy)
Shares / value: 446,428
Estimated value: $499,999
Report date: 06 Mar 2025
Price: $1.12
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: American Depositary Shares representing Ordinary Shares
Shares / value: 400,383
Estimated value: $448,429
Report date: 20 Mar 2025
Price: $1.12
Ownership: RPC Pharma Limited

Form 4 holding Director

Akari Therapeutics Plc

Security class: Pre-Funded Warrants to purchase ADRs
Shares / value: 386,661
Estimated value: $156,249
Report date: 16 Dec 2025
Price: $0.4041
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: American Depositary Shares representing Ordinary Shares
Shares / value: 19,355
Estimated value: $21,678
Report date: 20 Mar 2025
Price: $1.12
Ownership: Praxis Trustees Limited

Form 4 holding Director

Akari Therapeutics Plc

Security class: Warrants to purchase American Depositary Shares ("ADRs")
Shares / value: 618,658
Estimated value
Report date: 16 Dec 2025
Price
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Warrants to purchase ADRs
Shares / value: 386,661
Estimated value
Report date: 16 Dec 2025
Price
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Form 4 holding Director

Akari Therapeutics Plc

Security class: Stock Option (Right to Buy)
Shares / value: 225,000
Estimated value
Report date: 20 Mar 2025
Price
Ownership: Direct
Underlying class: American Depositary Shares representing Ordinary Shares
Underlying amount

Transaction history for Raymond Prudo-Chlebosz in Akari Therapeutics Plc

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .